m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A/Npas2/Hif‐1α axis
The FASEB Journal · 31.01.2025 · 39 (2)
DOI: 10.1096/fj.202403014r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 20.01.2025. Verfasst von Sai Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, People's Republic of Ch…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Glycolysis, Macrophage Activation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The National Science Foundation of China, The National Natural Science Foundation of China, Basic and Clinical Improvement Program of Anhui Meducal University.
Abstract (Originalsprache)
Macrophage infiltration and activation is a key factor in the progression of diabetic nephropathy (DN). However, aerobic glycolysis induced by m6A methylation modification plays a key role in M1‐type activation of macrophages, but the specific mechanism remains unclear in DN. In this study, the expression of m6A demethylase Fto in bone marrow derived macrophages and primary kidney macrophages from db/db mice. Loss and gain‐of‐function analysis of Fto were performed to assess the role of Fto in DN. Transcriptome and MeRIP‐seq association analysis was performed to identified the target gene was Npas2. In this study, we found that demethylase Fto exhibits low expression in type 2 DN m6A modification of Npas2 mediated by Fto regulates macrophages M1‐type activation and glucose metabolism reprogramming to participate in the process of DN. Furthermore, Fto reduces the m6A modification level of Npas2 in macrophages through a Prrc2a‐dependent mechanism, and decreasing its stability. This process mediates inflammation and glycolysis in M1 macrophages by regulating the Hif‐1α signaling pathway. Fto may act as a suppressor of M1 macrophages inflammation and glycolysis in DN through the m6A/Npas2/Hif‐1α axis. This findings providing a new basis for the prevention and treatment of DN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, People's Republic of China.
- Center for Scientific Research of Anhui Medical University, Hefei, Anhui, People's Republic of China.
ORCID-Profile: Sai Zhu, Ling Jiang, Xinran Liu, Chaoyi Chen, Xiaomei Luo, Shan Jiang, Jiuyu Yin, Xueqi Liu, Yonggui Wu
Förderung
- The National Science Foundation of China
- The National Natural Science Foundation of China
- Basic and Clinical Improvement Program of Anhui Meducal University
- 2022 Anhui Provincial Department of Education University research project
- National Natural Science Foundation of China
Zitieren
APA
Zhu, S., Jiang, L., Liu, X., Chen, C., Luo, X., Jiang, S., Yin, J., Liu, X., & Wu, Y. (2025). m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A/Npas2/Hif‐1α axis. The FASEB Journal, 39(2). https://doi.org/10.1096/fj.202403014r
Vancouver
Zhu S, Jiang L, Liu X, Chen C, Luo X, Jiang S, et al. m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A/Npas2/Hif‐1α axis. The FASEB Journal. 2025;39(2). doi:10.1096/fj.202403014r
BibTeX
@article{Zhu2025,
author = {Zhu, Sai and Jiang, Ling and Liu, Xinran and Chen, Chaoyi and Luo, Xiaomei and Jiang, Shan and Yin, Jiuyu and Liu, Xueqi and Wu, Yonggui},
title = {m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A/Npas2/Hif‐1α axis},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {2},
doi = {10.1096/fj.202403014r}
}
EUVIMED